Right. Hopefully they can sell off the excess stock for a profit, or staring down the barrel of large stock write offs in the second half.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025